The National Consumer Disputes Redressal Commission (NCDRC) recently directed a Ludhiana-based hospital and two of its doctors, including a neurologist and anaesthetist, to pay Rs ...
"It’s just a normal part of getting older." How many times have we heard this phrase used to dismiss early signs of cognitive ...
The findings were identified through an expanded MRI monitoring plan, implemented by REGENXBIO a few months ago, following the clinical hold related to RGX-111. The enhanced monitoring included both ...
Ultragenyx Pharmaceutical gains accelerated FDA approval for GENGLYCOS (GSDIa) at a $2.7M list, but launch may be slow. Read ...
A protein named tau, which has been strongly implicated in the world's No. 1 cause of dementia—Alzheimer's disease—and ...
REGENXBIO Inc. (Nasdaq: RGNX) today provided an update on its investigational gene therapy, RGX-121 (clemidsogene lanparvovec) ...
Anti-CD7 CAR T-Cell Therapy Shows Promising CNS Activity in Relapsed or Refractory T-ALL/LBL / Anti-CD7 CAR T, cancer, CAR ...
The Small Plasma Cell Clone Behind a Big Multisystem Disease / cancer, Castleman Disease, Hematology, OncoDaily, Oncology, ...
Researchers report that the flow of cerebrospinal fluid in the brain is linked to waking brain activity. The study demonstrates that manipulating blood flow in the brain with visual stimulation ...
The heart powers a busy highway of arteries and vessels, providing a constant to-and-fro passage for blood. During a heart ...
Research suggests addressing risk factors for poor cardiovascular health between the ages of 45 and 65 could help reduce risk of cognitive decline Scientists claim to have identified three health ...
Approximately 3 million people in the United States are living with a condition called heart failure with preserved ejection fraction, or HFpEF. The number of people with this form of heart failure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results